Bg pattern

VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Vispring 500 micrograms/ml eye drops in solution in single-dose containers

Tetrizoline Hydrochloride

Read the entire leaflet carefully before starting to use this medicine because it contains important information for you.

Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve after 48 hours.

Contents of the leaflet

  1. What Vispring in single-dose containers is and what it is used for
  2. What you need to know before starting to use Vispring in single-dose containers
  3. How to use Vispring in single-dose containers
  4. Possible side effects
  5. Storage of Vispring in single-dose containers
  6. Contents of the pack and additional information

1. What Vispring in single-dose containers is and what it is used for

Vispring belongs to the group of medicines called ophthalmic decongestants that act by producing ocular decongestion.

Vispring is indicated for the temporary symptomatic relief of mild conjunctival congestion in adults and children over 6 years old due to: smoke, wind, chlorinated water, light, and other irritants.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before using Vispring in single-dose containers.

Do not use Vispring in single-dose containers if

  • You are allergic to tetrizoline or any of the other components of this medicine (listed in section 6).
  • You have increased intraocular pressure (narrow-angle glaucoma).
  • You have heart disease or high blood pressure (hypertension).
  • You have a tumor in the adrenal glands (pheochromocytoma).
  • You have an overactive thyroid gland (hyperthyroidism).
  • You have controlled diabetes with insulin.
  • You are being treated with monoamine oxidase inhibitor antidepressants or other blood pressure-raising medications.
  • You have dry rhinitis.
  • You have inflamed cornea and conjunctiva (keratoconjunctivitis).
  • In children under 2 years of age.

Warnings and precautions

Consult your doctor or pharmacist before starting to use this medicine, especially:

  • If you have eye pain, headache, changes in vision, rapid appearance of floaters, redness or persistent irritation of the eye, pain after exposure to light or double vision. If this happens to you or if the conditions worsen or persist or if new symptoms appear, you should stop using the medicine and consult a doctor.
  • If you are over 65 years old.

When using this product, the pupils may temporarily dilate.

If you wear contact lenses, they should be removed before administering the medicine

Excessive or continuous use of this product can cause increased redness of the eye.

To avoid contamination of the product, do not touch any surface with the tip of the container. Do not use the product if the solution changes color or becomes cloudy.

Children and adolescents

Do not use in children under 2 years of age.

Using Vispring in single-dose containers with other medicines

Vispring cannot be used if you are being treated with:

  • Monoamine oxidase inhibitor antidepressants or
  • Blood pressure-raising medications.

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine, and in particular if you are using the following medicine, as it may be necessary to modify the dose of one of them:

  • Tricyclic antidepressants.

Consult your doctor before administering any other medicine via the ocular route; it is recommended to wait at least 5 minutes between both administrations.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

Vispring in single-dose containers has little or no influence on the ability to drive and use machines. In rare cases, the ability to drive and use machines may be altered due to blurred vision or glare.

3. How to use Vispring in single-dose containers

Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

This medicine is administered via the ocular route.

The recommended dose is:

Adults and children over 6 years old: 1 or 2 drops in the affected eyes 2 or 3 times a day as needed, up to a maximum of 4 times a day.

Children from 2 to 6 years old: Use only under strict medical control

The amount of Vispring in single-dose containers is sufficient for a single use in both eyes. Once a single-dose container is separated from the strip and the closure device is removed, apply the drops to the eye by gently pressing the container. After application, it is convenient to blink gently for a few seconds to facilitate uniform distribution of the drops.

Discard the container after each use.

It should only be used for minor eye irritations. If you do not get relief within 48 hours or if the redness increases or persists, discontinue use and consult your doctor.

It should only be used until the symptoms disappear and never for more than a week.

If you use more Vispring in single-dose containers than you should

Excessive use or oral ingestion can lead to cardiovascular instability, central nervous system depression including somnolence and coma, and respiratory depression including apnea.

There is a risk, especially in neonates and children, due to absorption of the product, for example, due to ingestion.

The symptoms associated with overdose are dilation of the pupil of the eye, bluish discoloration of skin and mucous membranes, vomiting, sedation, somnolence, stupor, drooling, nausea, fever, cramps, alteration of heart rhythm, cardiac arrest, increased blood pressure, pulmonary edema, respiratory and mental alterations.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91.562.04.20 (indicating the medicine and the amount ingested).

If you forget to use Vispring in single-dose containers

Do not use a double dose to make up for forgotten doses.

If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Vispring can cause side effects, although not everybody gets them.

Frequent (may affect up to 1 in 10 patients): Ocular irritation (pain, itching, burning), visual disturbances.

Uncommon (may affect up to 1 in 100 people): Burning of the ocular mucosa, dry eye, rebound hyperemia, palpitations, headache, tremor, weakness, sweating, and increased blood pressure.

Rare (may affect up to 1 in 1,000 patients): Blurred vision, irritation of the ocular conjunctiva, and dilation of the pupil (mydriasis).

Very rare (may affect up to 1 in 10,000 people): Reactions at the application site (including ocular or periocular burning, erythema, irritation, edema, pain, and itching).

Unknown (frequency cannot be estimated from available data): Increased lacrimation.

Prolonged and frequent use can cause dry eye syndrome.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines and Health Products Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Vispring in single-dose containers.

Do not store above 25°C.

Keep out of sight and reach of children.

Do not use this medicine after the expiration date stated on the carton after EXP.

The expiration date is the last day of the month indicated.

Discard the container after each use

Medicines should not be disposed of via wastewater or household waste. Deposit the containers and medicines you no longer need in the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the containers and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and additional information.

Composition of Vispring in single-dose containers

  • The active ingredient is tetrizoline hydrochloride. Each ml contains 500 micrograms of tetrizoline hydrochloride as the active ingredient. Each single-dose container of 0.5 ml contains 250 micrograms of tetrizoline hydrochloride
  • The other components (excipients) are: Boric acid (E-284), sodium borate, sodium chloride, and purified water.

Vispring in single-dose containers is a clear and colorless eye drop solution presented in 0.5 ml single-dose containers. Each box contains 10 single-dose containers.

Marketing authorization holder and manufacturer

Marketing authorization holder

JNTL Consumer Health (Spain), S.L.

C/ Vía de los Poblados 1, Edificio E, planta 3

28033-Madrid

Spain

ManufacturerLABORATOIRE UNITHER

Rue De L Arquerie

Coutances, 50200

France

Date of the last revision of this leaflet: November 2017

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es

Online doctors for VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS

Discuss questions about VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (4)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (34)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€0
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS?
VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS?
The active ingredient in VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS is tetryzoline. This information helps identify medicines with the same composition but different brand names.
Who manufactures VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS?
VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS is manufactured by Jntl Consumer Health (Spain) S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to VISPRING 500 micrograms/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS?
Other medicines with the same active substance (tetryzoline) include OPTISPRING 0.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS, OPTISPRING 0.5 mg/ml EYE DROPS SOLUTION, VISPRING 0.5 mg/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media